Carlsmed Inc (CARL)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Carlsmed Inc Stock (CARL) Company Profile

Carlsmed Inc

Healthcare (1106)

858-295-9290

1800 ASTON AVENUE, CARLSBAD

Prossima data di guadagno

Ultimi documenti SEC

CARL's Discussions on Twitter

Compare CARL vs VEEV, TEM, BTSG, HQY, WAY

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CARL Carlsmed Inc	12.99	351.29M	0	0	0	0.00
VEEV Veeva Systems Inc	188.48	30.56B	3.08B	860.33M	1.35B	5.1463
TEM Tempus Ai Inc	51.29	9.19B	1.27B	-245.03M	-245.36M	-1.4071
BTSG Brightspring Health Services Inc	41.96	7.33B	11.99B	24.18M	234.31M	0.2956
HQY Healthequity Inc	81.15	6.87B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	26.93	5.09B	906.14M	-52.62M	89.62M	-0.3621

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-18	Iniziato	BTIG Research	Buy
2025-08-18	Iniziato	BofA Securities	Buy
2025-08-18	Iniziato	Goldman	Buy
2025-08-18	Iniziato	Piper Sandler	Overweight
2025-08-18	Iniziato	Truist	Buy

Carlsmed Inc Borsa (CARL) Ultime notizie

Carlsmed Inc Azioni (CARL) Dati Finanziari

Non sono disponibili dati finanziari per Carlsmed Inc (CARL). Controlla altri titoli per ulteriori informazioni.

Carlsmed Inc Azioni (CARL) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Cordonnier Michael	CEO, President	Mar 02 '26	Option Exercise	0.34	197,855	66,281	1,554,501
Cordonnier Michael	CEO, President	Mar 02 '26	Sale	13.29	197,855	2,629,889	1,356,646

Carlsmed Inc (CARL)

Carlsmed Inc Stock (CARL) Company Profile

Compare CARL vs VEEV, TEM, BTSG, HQY, WAY

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Carlsmed Inc Borsa (CARL) Ultime notizie

CARL: Personalized spine surgery platform posts 86% annual growth and expands into cervical market - TradingView

CARL: Personalized spine surgery platform drives rapid growth, clinical success, and strong reimbursement - TradingView

Brokerages Set Carlsmed, Inc. (NASDAQ:CARL) Target Price at $21.33 - Defense World

Carlsmed (CARL) versus Its Peers Financial Contrast - Defense World

Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Wave Life Sciences (WVE) and Carlsmed, Inc. (CARL) - The Globe and Mail

Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Carlsmed (NASDAQ:CARL) Lowered to Strong Sell Rating by Zacks Research - MarketBeat

Head to Head Survey: Carlsmed (CARL) versus Its Competitors - Defense World

Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer

Carlsmed Q4 Earnings Call Highlights - MarketBeat

Carlsmed, Inc. Reports Strong Q4 2025 Earnings and Growth Outlook - Intellectia AI

Carlsmed Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Carlsmed Inc (NASDAQ:CARL) Reports Q4 Revenue Beat and Narrower-Than-Expected Loss - ChartMill

Earnings call transcript: Carlsmed reports strong revenue, stock dips Q4 2025 - Investing.com

Carlsmed (NASDAQ:CARL) Issues Quarterly Earnings Results - MarketBeat

CARL: 2025 revenue surged 86% with expanding margins and strong adoption of new spine surgery products - TradingView

CARL: 2025 revenue surged 86% with expanding margins; 2026 guidance targets $70–$75M and robust growth - TradingView

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times

Carlsmed, Inc. Provides Revenue Guidance for the Year 2026 - marketscreener.com

Head to Head Comparison: Carlsmed (CARL) versus Its Competitors - Defense World

Carlsmed announces clinical debuts of two spinal surgery solutions - Today's Medical Developments

Carlsmed Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget

Carlsmed Unveils Custom Cervical Plating Tech - National Today

Carlsmed Inc expected to post a loss of 43 cents a shareEarnings Preview - TradingView

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference - marketscreener.com

Head to Head Survey: Carlsmed (NASDAQ:CARL) & Check-Cap (NASDAQ:MBAI) - Defense World

Financial Contrast: Carlsmed (CARL) and Its Competitors - Defense World

Carlsmed Announces first corra™ personalized Cervical Plating Procedure - Orthopedics This Week

Carlsmed Announces first corra personalized Cervical Plating Procedure - Bitget

Analyzing Carlsmed (CARL) & Its Competitors - Defense World

CARL Should I Buy - Intellectia AI

Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to “Hold” - Defense World

Financial Review: Carlsmed (CARL) versus Its Rivals - Defense World

Critical Comparison: Carlsmed (NASDAQ:CARL) vs. TransEnterix (OTCMKTS:TRXDW) - Defense World

Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - The Manila Times

Carlsmed completes first surgery using aprevo bilateral posterior system By Investing.com - Investing.com Canada

Carlsmed completes first surgery using aprevo bilateral posterior system - Investing.com Nigeria

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure - Orthopedics This Week

Both private equity firms who control a good portion of Carlsmed, Inc. (NASDAQ:CARL) along with institutions must be dismayed after last week's 11% decrease - simplywall.st

TD Waterhouse Canada Inc. Takes $2.03 Million Position in Carlsmed, Inc. $CARL - MarketBeat

Teacher Retirement System of Texas Purchases Shares of 175,000 Carlsmed, Inc. $CARL - MarketBeat

Financial Comparison: Carlsmed (NASDAQ:CARL) & ReShape Lifesciences (OTCMKTS:RSLSD) - Defense World

Bullish Carlsmed Insiders Loaded Up On US$8.10m Of Stock - Yahoo Finance

Analyzing Carlsmed (NASDAQ:CARL) and Perspective Therapeutics (NASDAQ:CATX) - Defense World

Carlsmed (NASDAQ:CARL) Downgraded to Sell Rating by Wall Street Zen - MarketBeat

BTIG Reiterates Buy Rating on CARL, Maintains Price Target | CAR - GuruFocus

AI medtech firm Carlsmed prices $100.5M IPO - MSN

California-based Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer

Carlsmed reports 61% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria

Carlsmed Inc Azioni (CARL) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Carlsmed Inc Azioni (CARL) insider trading

Simile a CARL